Sanders Corazon (Corsee) D. — SEC Form 4 filings
SEC reporting owner CIK 1796536. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-07 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 12,230 shares, $2,094,618 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 2,665 shares @ $337.00 ($898,105) in BeOne Medicines Ltd., filed 2025-09-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | Director | 5 | — | 4 legs · 5,504 sh · $1,859,272 | 8 |
| Ultragenyx Pharmaceutical Inc. (RARE) | Director | 7 | — | 4 legs · 6,726 sh · $235,346 | 6 |
| Calidi Biotherapeutics, Inc. (CLDI) | Director | 1 | — | — | 1 |
| Molecular Templates, Inc. (MTEM) | Director | 1 | — | — | 1 |
Form 4 filings — Sanders Corazon (Corsee) D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Calidi Biotherapeutics, Inc. (CLDI) | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 2,000 @ $25.05 | EDGAR |
| 2026-05-27 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 212 @ $309.59 | EDGAR |
| 2026-05-18 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 7,751 @ $0 · Grant/award (A): 14,058 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 2,627 @ $159.03 · Sale (S): 1,823 @ $340.20 · Sale (S): 804 @ $342.47 · Option exercise (M): 34,151 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 2,665 @ $155.68 · Sale (S): 2,665 @ $337 · Option exercise (M): 34,645 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 2,405 @ $37.39 | EDGAR |
| 2025-05-22 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 10,985 @ $0 · Grant/award (A): 22,750 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 5,740 @ $0 · Grant/award (A): 10,787 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Molecular Templates, Inc. (MTEM) | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 584 @ $40.98 | EDGAR |
| 2024-06-20 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 5,345 @ $0 · Grant/award (A): 9,900 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 1,737 @ $41.10 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 16,341 @ $0 · Grant/award (A): 34,151 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796536 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →